Active site binding modes of curcumin in HIV-1 protease and integrase

被引:100
|
作者
Vajragupta, O
Boonchoong, P
Morris, GM
Olson, AJ
机构
[1] Mahidol Univ, Fac Pharm, Dept Pharmaceut Chem, Bangkok 10400, Thailand
[2] Ubon Rajathanee Univ, Fac Pharmaceut Sci, Div Pharmaceut Chem & Technol, Ubon Ratchathani 34190, Thailand
[3] Scripps Res Inst, Dept Mol Biol, Mol Graph Lab, La Jolla, CA 92037 USA
关键词
curcumin; HIV-1; HIV integrase; HIV protease; 5-CITEP; docking;
D O I
10.1016/j.bmcl.2005.05.032
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure models for the interaction of curcumin with HIV-1 integrase (IN) and protease (PR) were investigated using computational docking. Curcumin was found to bind preferentially in similar ways to the active sites of both IN and PR. For IN, the binding site is formed by residues Asp64, His67, Thr66, Glu92, Thr93, Asp116, Ser119, Asn120, and Lys159. Docked curcumin contacts the catalytic residues adjacent to Asp116 and Asp64, and near the divalent metal (Mg2+). In the PR docking, the curcumin structure fitted well to the active site, interacting with residues Asp25, Asp29, Asp30, Gly27', Asp29', and Asp30'. The results suggest that o-hydroxyl and/or keto-enol structures are important for both IN and PR inhibitory actions. The symmetrical structure of curcumin seems to play an important role for binding to the PR protein, whereas the keto-enol and only one side of the terminal o-hydroxyl showed tight binding to the IN active site. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3364 / 3368
页数:5
相关论文
共 50 条
  • [41] COSALANE ANALOGS WITH ENHANCED POTENCIES AS INHIBITORS OF HIV-1 PROTEASE AND INTEGRASE
    CUSHMAN, M
    GOLEBIEWSKI, WM
    POMMIER, Y
    MAZUMDER, A
    REYMEN, D
    DECLERCQ, E
    GRAHAM, L
    RICE, WG
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (03) : 443 - 452
  • [42] Inhibition of HIV-1 reverse transcriptase and its binding to HIV-1 integrase by modified oligonucleotides
    Korolev, S.
    Kondrashina, O.
    Lysenko, E.
    Gottikh, M.
    FEBS JOURNAL, 2013, 280 : 84 - 85
  • [43] Mechanism of substrate binding to HIV-1 protease
    Toth, G
    Borics, A
    Meshkat, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U799 - U799
  • [44] The binding energy of HIV-1 protease inhibitor
    Ka, J
    Park, SH
    Kim, H
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 1996, 17 (01) : 19 - 24
  • [45] Binding to the open conformation of HIV-1 protease
    Lexa, Katrina W.
    Carlson, Heather A.
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2011, 79 (07) : 2282 - 2290
  • [46] Identification of cellular factors binding to acetylated HIV-1 integrase
    Allouch, Awatef
    Cereseto, Anna
    AMINO ACIDS, 2011, 41 (05) : 1137 - 1145
  • [47] HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants
    Smith, Steven J.
    Zhao, Xue Zhi
    Passos, Dario Oliveira
    Lyumkis, Dmitry
    Burke, Terrence R., Jr.
    Hughes, Stephen H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [48] Identification of cellular factors binding to acetylated HIV-1 integrase
    Awatef Allouch
    Anna Cereseto
    Amino Acids, 2011, 41 : 1137 - 1145
  • [49] HIV-1 integrase: Thermodynamics of oligomerization and the effects of DNA binding
    Reily, MM
    Harvey, JJ
    Knutson, JR
    Han, MK
    Lewis, MS
    BIOPHYSICAL JOURNAL, 2003, 84 (02) : 505A - 505A
  • [50] Defining the DNA Substrate Binding Sites on HIV-1 Integrase
    Dolan, James
    Chen, Aiping
    Weber, Irene T.
    Harrison, Robert W.
    Leis, Jonathan
    JOURNAL OF MOLECULAR BIOLOGY, 2009, 385 (02) : 568 - 579